Research March 25 2025 2025-03-25

A new biological treatment shows rapid and lasting efficacy in severe chronic rhinosinusitis with nasal polyps

Researchers from Clínic-IDIBAPS have participated in an international study published in The New England Journal of Medicine (NEJM), which demonstrates that tezepelumab, a biological drug, significantly reduces the size of nasal polyps and improves symptoms in patients with severe chronic rhinosinusitis with nasal polyps.

Dr. Joaquim Mullol, study coauthor.

Related contents
Keep reading about: